GOVERNANCE

Executive Committee

Executive Committee members

Karl Rotthier

Chief Executive Officer
Learn more

Karl Rotthier

Chief Executive Officer

Appointed: January 2021
Nationality: Belgian

Karl Rotthier is CEO of EUROAPI. With nearly three decades spent in senior management positions, he also brings to his role strong API (Active Pharmaceutical Ingredients) business experience.

Karl has a strong track record in carve-out and spin-off operations. At EUROAPI, he’s put together a committed management team that reflects the DNA of an efficient company: agility, and the ability to unlock its growth potential.

His international career has included positions in Europe and further afield, such as in Singapore. Karl started his career as a lawyer in Belgium and worked for BASF in Belgium and Germany leading, amongst others, the Performance Chemicals business unit of BASF in Ludwigshafen. He then joined DSM and became CEO of DSM Sinochem Pharmaceuticals. More recently, he was CEO of Centrient Pharmaceuticals.

Karl holds master’s degrees in Law from the University of Antwerp (Belgium) and the University of Southampton (UK), and an MBA from Vlerick Business School‎ (Belgium).

Married and a father of two, Karl is a football, skiing and golf fan, and enjoys travel, art and music.

Antoine Delcour

Chief Financial Officer
Learn more

Antoine Delcour

Chief Financial Officer

Appointed: February 2020
Nationality: French

Antoine Delcour is the Chief Financial Officer at EUROAPI. He previously held the same position at Sanofi Active Ingredient Solutions. Antoine has been with the Sanofi Group since 2014, and has led many strategic projects (industrial JV, acquisitions, divestments, licenses) while developing his leadership, negotiation and strategic skills.

He started his career in 2001 at Unilever as a Manufacturing Controller. He then served as Marketing Controller for the personal care segment in France.

In 2006, he moved to Schlumberger, where he held various positions in finance. He became CFO of one of the company’s American plants and development centers before moving to Vietnam to serve as country CFO. He later moved back to Europe to work as the European tax manager in Paris.

Antoine graduated from the ESSEC Business School and holds a post-graduate degree in Food Industry Management. He also has a master’s degree in Applied Biology and Industrial Processes.

In his free time, Antoine enjoys traveling, spending time with family and friends, and attending concerts in a wide range of genres.

Cécile Maupas

Chief CDMO Officer
Learn more

Cécile Maupas

Chief CDMO Officer

Appointed: October 2020
Nationality: French

Cécile Maupas, with her long experience in Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, joined Sanofi in 2020 as Head of CDMO and Business Scouting for Sanofi Active Ingredient Solutions. Cécile is an expert in the management of new and transforming organizations. She is also skilled in business development, customer-centricity, and sales team management.

She started her career as Sales Manager at GE Healthcare Life Sciences, promoting innovative biotechnology solutions. She went on to become Strategic Account Manager for pharma and biopharma customers, a position she held for 10 years.

She then spent eight years at Novasep, where she developed the CDMO biopharma business. There, she led its European and Asian Business Development team as the CDMO Biopharma Sales Director. Before joining Sanofi, she also contributed to the growth of Pierre Fabre’s CDMO Injectables and Biotech business worldwide. 

Cécile graduated from the University of Paris, and she holds a master’s degree in Biochemistry applied to biological and medical engineering.

Cécile is passionate about Jazz music and Latin dance. She likes cooking for friends, family and enjoys simple moment like seeing her daughter laughing, watching the countryside, ocean, nature and sharing a good bottle of Burgundy wine with close friends and relatives.

Laurent Alexandre

Chief Commercial Officer
Learn more

Laurent Alexandre

Chief Commercial Officer

Appointed: October 2021
Nationality: French

Laurent Alexandre is Chief Commercial Officer at EUROAPI. He is tasked with developing and leading the company’s API portfolio strategy, as well as contributing to the IPO planned for later this year. He has been with the group since 2021 and brings with him extensive international experience.

He began his career in 2001 as Sales Manager at IMCD and Axyntis, a position he held until 2007. He then joined PCAS as Sales Manager for the U.S. market, becoming Sales Director and a member of the Executive Committee in 2010.

From 2012 to 2019, Laurent served as PCAS General Manager in the U.S. He was head of the generic API business line until 2019, when the company was acquired. More recently, he worked in the healthcare sector, where he served as Global Commercial Director at Johnson Matthey.

Laurent graduated with a master’s degree in Biochemistry from Paris VI University in 1999 and a DESS degree in Science & Management in 2000.

Laurent enjoys traveling and also holds an air pilot’s license.

Eric Berger

Chief Operating Officer
Learn more

Eric Berger

Chief Operating Officer

Appointed: February 2020
Nationality: French

Eric Berger is Chief Operating Officer of EUROAPI managing industrial operations, development and Innovation and the procurement function at local and central level.

He began his career in Canada in Biotech Process Development before joining Roussel Uclaf. After three years as leader of Synkem, Eric joined Aventis as head of the Vertolaye site, before moving to Neuville-sur-Saone where he led the project to create a new vaccines campus for Sanofi Pasteur.

In 2011, Eric moved to the U.S. to manage company integration and manufacturing for Genzyme as Vice President of Biologics Industrial Operations. He then returned to Sanofi Pasteur in 2013 to serve as a Regional Vice President of Industrial Operations, leading the six American sites.

For the past three years, he has worked as Head of Global Industrial Affairs Manufacturing Excellence at Sanofi.

Eric holds a bachelor/master’s degree in chemical engineering, biotechnology, biochemical engineering, and cell culture and fermentation from Polytechnique Montréal. He participated in INSEAD’s General Management program in 2002.

Eric is passionate about rugby and traveling.

Vincent Touraille

Chief Strategy and M&A Officer
Learn more

Vincent Touraille

Chief Strategy and M&A Officer

Appointed: October 2020
Nationality: French

Vincent Touraille was appointed Chief Strategy and M&A Officer at EUROAPI in 2020. His tasks include corporate strategy but also the team management for platforms, products strategy and partnerships.

Vincent has worked in the pharmaceutical industry for more than 20 years, developing his expertise in management and strategy. He started at Shell in 1989 and hold different growing positions. From 2009 to 2019, he served as Chief Executive Officer of PCAS, a French stock market listed CDMO acquired by Novacap in 2018.

In 2019, as Deputy Chief Executive Officer at M2i Lifesciences, he reorganized the company and led its evolution into a medium-sized international group.

Since October 2020, Vincent has been Head of Strategy at Sanofi Active Ingredient Solutions, where he has prepared the launch of EUROAPI as a standalone company.

He graduated from ENSCP (National Graduate School of Chemistry, Paris) in 1986 and ESSEC in 1989.

Vincent is Board member of France Chimie, the French chemical Society and the President of SICOS Biochimie, the representative body for manufacturers of fine chemicals located in France. He is also Board Member of European Fine Chemical Group, its European equivalent.

Vincent is passionate about spending time with family, reading novels and history. He regularly practices tennis and running.

Kai Rossen

Chief Scientific Officer
Learn more

Kai Rossen

Chief Scientific Officer

Appointed: October 2020
Nationality: German

Kai Rossen is Chief Scientific Officer of EUROAPI. His mission consists to ensure that EUROAPI is further strengthening its level of scientific and technical competence, drive increased innovation and project these capabilities to the outside

Kai began his career at Bayer. From 1990, he spent 10 years in the U.S. working for Merck in Rahway (New Jersey) in the Process Research Department, where he was involved in catalyst development and in the synthesis of several currently marketed drugs.

In 2000, he joined the Fine Chemicals Division of Degussa (now Evonik) before returning to the pharmaceutical industry at Sanofi in 2006. Then, he served as Vice President of Process Chemistry at Lundbeck in Copenhagen from 2017-2020.

Kai holds a Master of Science from the University of North Carolina at Chapel Hill (U.S.), the Diplomchemiker degree from the University of Düsseldorf. He also holds a Ph.D. from Cornell University (U.S.).

Since 2015, Kai has been the Editor-in-Chief of the journal Organic Process Research & Development, which is issued by the American Chemical Society.

In his free time, Kai is interested in history with a focus on Denmark.

James DeYonker

Chief Legal, Compliance, and IP Officer
Learn more

James DeYonker

Chief Legal, Compliance, and IP Officer

Appointed: October 2021
Nationality: American

James DeYonker is the Chief Legal, Compliance, and IP Officer for EUROAPI. He has been with the company since October 2021, when he was brought on board to prepare the company for the IPO process and to help drive the transformation to the new business model. He brings with him extensive international experience, having worked on the ground in Europe, US, China, India, Japan, and Mexico, in a wide array of pharmaceutical legal matters.

James began his career as Global Intellectual Property Counsel and Head of IP for API and CDMO companies such as Ranbaxy-Sun Pharmaceuticals and Polpharma. James also has experience in private practice as a Corporate Law Associate at Linklaters LLP.

He became Head of Legal EU and Global Respiratory for Cipla Pharmaceuticals in 2012, then Global Senior IP Counsel at Mondelez International in 2014. In 2016, he became Chief Legal and Compliance Officer & Head of Intellectual Property and Innovation at Centrient Pharmaceuticals.

James holds a bachelor’s degree in Molecular Biology and Microbiology from Emory University (Georgia) and a Juris Doctorate from the Rutgers University School of Law (New Jersey). James is also a registered US Patent Attorney.

In his free time, he enjoys surfing, playing golf, skiing, and a good glass of red wine. He’s also the proud owner of two rescue dogs.

Bruno Laforge

Chief Human Resources and Corporate Affairs Officer
Learn more

Bruno Laforge

Chief Human Resources and Corporate Affairs Officer

Appointed: 2021
Nationality: French

Bruno Laforge is Chief Human Resources and Corporate Affairs Officer. He has been with the Sanofi Group since 2011, joining with the group in Research & Development as Head of Global HR. There, he worked in the vaccines Global Business Unit from 2015 to 2017 as Senior Vice President HR and became Head of HR for Europe and France in August 2017. He also served in the meantime as Business Partner HR for Sanofi Business Transformation.

Bruno’s career began in early 90’s in various industries and became HR Director at Johnson & Johnson, for France and Benelux in 1999. In 2001, he took over Human Resources at Guilbert, and then became Head of Human Resources for Europe at Office Depot. In 2007; He became Vice President of HR at Geoservices (Oil & Gas LBO with a venture capital), where he also served as head of Mergers & Acquisitions until 2010,

Bruno holds master’s degrees in Economics and History, a Higher Diploma in Human Resources from Sciences Po, and an MBA from HEC.

Having lived in several countries, in the U.S, Singapore, and Netherlands, Bruno likes the diversity of cultures, and is passionate about car racing, golf and modern paintings.

Frédéric Lelievre

Chief Quality Officer
Learn more

Frédéric Lelievre

Chief Quality Officer

Appointed: February 2020
Nationality: French

Frédéric Lelievre is EUROAPI’s Chief Quality Officer. He joined Sanofi’s Corporate Quality Division in 2014 and led the Quality division of the 12 chemical sites. In this position, he has ensured that GMP products and systems have met regulatory requirements and those of the company's Quality Management System. In parallel, he has applied his expertise in the deployment of new regulations, and in performance and innovation initiatives.

Frédéric started his career in 1997 as the Quality Control Manager of the Vertolaye chemistry site (then owned by Roussel Uclaf), and then served as the Site Quality Manager from 2001 to 2005.

He became Site Quality Manager at Sanofi Aramon in 2006, with a specific focus on chemistry and biotechnology. From 2011 to 2014, he worked at Sanofi Compiègne, where he focused on the production of Drug Products Solid Dosage Forms.

Frédéric holds a degree in Physics and Chemistry from ESPCI Paris engineer school, and a Ph.D. with Highest Honors in Analytical Chemistry from ENSCP (Paris) and Stanford University (U.S.).

Frédéric is passionate about sports such as soccer, running, hiking, and travelling aiming to discover nature and beautiful landscapes.

Emmanuel Mazeaud

Chief Digital Officer
Learn more

Emmanuel Mazeaud

Chief Digital Officer

Appointed: 2021
Nationality: French

Emmanuel Mazeaud has worked for Sanofi since 2017, when he started as Program Manager of the Athena for Vaccines program. For over four years, he has led the ITS Industrial Affairs organization for all pharma and chemistry sites worldwide. His business acumen and comprehensive experience span a wide range of IT and Functional Shared Services roles, with a solid background in driving transformation (IT and non-IT) through Shared Services implementation, reorganization, and M&A.

 Emmanuel held several executive IT management positions in various countries to begin his career. Prior to joining Sanofi, he was CEO of Holcim East Asia Business Services in the Philippines, and Head of IT and Business Services for the APAC region.

He was instrumental in the merger of Lafarge and Holcim in the region, managing the SAP integration and the migration of all countries to Regional Business Shared Services. He also played key roles in divestments, business development and digital transformation.

He graduated from ENSIEG (National School of Electrical Engineers of Grenoble) in 1988.

Emmanuel enjoys running, playing golf, and practicing scuba diving as well as cooking and making pastries for family and friends.

ExCom permanent invitees

Géraldine Gorgol

Head of Corporate Affairs
Learn more

Géraldine Gorgol

Head of Corporate Affairs

Appointed: 2020
Nationality: French

Géraldine Gorgol is Head of Corporate Affairs for EUROAPI, which includes Communications, Public Affairs, Environment Social and Governance (ESG), and Risk Management. She has spent 25 years in the Sanofi Group. For the three years prior to her current role, she was Head of Marketing, Business Intelligence and Communications at Sanofi Active Ingredient Solutions.

Géraldine began her career at Sanofi as part of the Marketing and Sales team, where she managed web projects, customer experience initiatives and Key Opinion Leaders.

Later, she managed several brands’ strategies at different stages of the product lifecycle, from launch to generic competition, taking on increasing marketing responsibilities.

Géraldine then joined the Corporate Communications team in 2008 to lead Digital Communications. She later held global positions in Procurement and Shared Business Services as a Communications Business Partner.

She graduated from the University of Nancy, where she studied Marketing and Sports Management.

Géraldine enjoys contemporary art, electronic music, and reading.

Guillaume Rosso

Head of Investor Relations
Learn more

Guillaume Rosso

Head of Investor Relations

Appointed: January 2022
Nationality: French

Guillaume Rosso is Head of Investor Relations for EUROAPI. In this role he implements and oversees strategies for financial communications and the target shareholding structure. He engages with external stakeholders and is the primary contact for EUROAPI shareholders.

Guillaume joined the Sanofi Group in 2017, working on key M&A projects before being appointed IPO M&A Manager in 2020. In this role, he led the Pluton project, heading up the preparation and execution of the EUROAPI IPO process.

Guillaume brings over 13 years of experience in the pharmaceutical industry to this position. His career began at PwC, where he was first an auditor and later the Transaction Services Manager.

He is a graduate of EM LYON business school, where he holds a degree in Finance – Management.

In his free time, Guillaume loves to travel and experience other cultures.